Loading...

News Analysis

» business and CRISPR

Most Recent

image: Top Technical Advances in 2017

Top Technical Advances in 2017

By Shawna Williams | December 25, 2017

The year’s most impressive achievements include new methods to extend CRISPR editing, patch-clamp neurons hands-free, and analyze the contents of live cells.

1 Comment

image: 2017’s Science News in Review

2017’s Science News in Review

By Kerry Grens | December 15, 2017

Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By Claire Asher | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: RNAi’s Future in Drug-Target Screening

RNAi’s Future in Drug-Target Screening

By Catherine Offord | April 17, 2017

A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

0 Comments

image: With CRISPR, Modeling Disease in Mini Organs

With CRISPR, Modeling Disease in Mini Organs

By Tanya Lewis | May 6, 2016

Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.

0 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By Tracy Vence | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Credit for CRISPR: A Conversation with George Church

Credit for CRISPR: A Conversation with George Church

By Bob Grant | December 29, 2015

The media frenzy over the gene-editing technique highlights shortcomings in how journalists and award committees portray contributions to scientific discoveries.

9 Comments

image: Year in Review: CRISPR Blossoms

Year in Review: CRISPR Blossoms

By Jef Akst | December 16, 2015

As researchers work to improve the precision gene-editing technology, the community discusses the best way to use it.

0 Comments

image: The Unregulation of Biotech Crops

The Unregulation of Biotech Crops

By Kerry Grens | November 25, 2015

Genetic engineering—once a trigger for federal oversight—is now ushering some modified crops around scrutiny.

2 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By Jenny Rood | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

7 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. RNA Injection Restores Hearing in Guinea Pigs
  4. Jim Bridenstine Confirmed to Lead NASA